Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
China Journal of Chinese Materia Medica ; (24): 2503-2507, 2015.
Artículo en Inglés | WPRIM | ID: wpr-284784

RESUMEN

Allergic reactions caused by traditional Chinese medicine injections (TCMIs) become a greatest concern in the clinic application safety. The integral animal evaluation method commonly used in the preclinical evaluation for allergic reactions of TCMIs was not sensitive, specific, quick and objective in observation indexes. Therefore, more researchers have paid attention to the in vitro test method for evaluating allergic reactions induced by TCMIs. Currently, the methods for evaluating allergic reactions induced by TCMIs are mainly targeted at type I allergic reaction and anaphylactic reaction, with only a few in vitro methods for evaluating type II allergic reaction. In this paper, researchers summarized relevant literatures published about evaluation methods for allergic reactions induced by TCMIs in recent years.


Asunto(s)
Animales , Humanos , Activación de Complemento , Hipersensibilidad a las Drogas , Diagnóstico , Inyecciones , Medicina Tradicional China
2.
Acta Pharmaceutica Sinica ; (12): 1199-1203, 2011.
Artículo en Chino | WPRIM | ID: wpr-233012

RESUMEN

This study is to investigate the effect of compound B2 on the damage of PC12 cells induced by serum deprivation and to explore its related mechanisms. The binding characteristics of B2 to rat striatum adenosine A2A receptor was studied by radioligand 3H-MSX-2 binding assay. Cell viability was detected by MTT assay. ROS formation was measured after DCFDA fluorescent staining. B2 has affinity to rat adenosine A2A receptor (K1 = 0.37 micromol x L(-1)). B2 remarkably increased PC12 cell survival rate in serum deprivation-induced PC12 cells. The percentage of serum deprivation-induced death of PC12 was 49.6%, and the treatment of B2 (0.1-100 micromol x L(-1)) increased the cell viability to 63.3%, 74.9%, 86.3% and 88.1%, respectively. Adenosine A2A receptor antagonist SCH 58261 could significantly block the protective effect of B2. The cell viability with 0.1 micromol x L(-1) SCH 58261 decreased by 16.1%, 24.0% and 19.8%, in the presence of B2 (0.1-10 micromol x L(-1)). Serum deprivation-induced ROS formation was 3.5 times more than that of control group, and treatment with B2 significantly and dose-dependently inhibited ROS over-formation. The protective effect of B2 may be related with adenosine A2A receptor. Decrease of serum-deprivation induced ROS formation may also be one of the mechanisms.


Asunto(s)
Animales , Femenino , Masculino , Ratas , Adenosina , Metabolismo , Farmacología , Antagonistas del Receptor de Adenosina A2 , Farmacología , Supervivencia Celular , Cuerpo Estriado , Metabolismo , Medio de Cultivo Libre de Suero , Células PC12 , Pirimidinas , Farmacología , Ratas Wistar , Especies Reactivas de Oxígeno , Metabolismo , Receptor de Adenosina A2A , Metabolismo , Triazoles , Farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA